[Adhesions and chronic XXXX ].

@entity1 @entity249 @entity2371 @entity1744 @entity2531 @entity490 @entity158 @entity1118 @entity130
OBJECTIVES: To analyse pathophysiology of adhesions and their link with chronic @entity2371 , as well as therapeutic and prevention options as reported in the literature. MATERIAL AND METHODS: Review of articles and consensus conferences published on this topic in the Medline (Pubmed) database, selected according to their scientific relevance. RESULTS: Postoperative adhesions are responsible for a specific morbidity combining @entity1118 , @entity1744 , @entity249 , and morbidity increase in the event of subsequent surgery. @entity1118 in previously operated on @entity1 can be linked to postoperative adhesions. Ultrasonography and dynamic MRI can recognize intra abdominal adhesions, but cannot definitely link them to the @entity2531 . The prevention of adhesions is done firstly by respecting surgical rules concerning laparoscopic and open surgical approaches, and secondly by the use of anti-adhesion products. Pharmacological adhesion prevention systems decrease the frequency and extent of adhesions. Their efficiency has been proved by studies with substantial evidence levels. @entity1 suffering from potentially adhesion-induced chronic @entity490 can benefit from a laparoscopic adhesiolysis, which improved @entity158 symptoms in more than 50% of @entity1 , but exposes to the risk of complications, such as @entity130 . CONCLUSION: The decision to perform adhesiolysis should be taken for each @entity1 individually, while taking in consideration the benefit-to-risk ratio. Adhesion relapse after adhesiolysis is a frequent phenomenon, but can be reduced by the use of anti-adhesion products.
